Longevity UnmaskedLongevity Unmasked

Question 34 of 433

Should I take a daily baby aspirin?

Evidence grade (draft mapping)ARobust human trials
A few small plain tablets and a glass of water on dark marble

The short answer

Do not start aspirin routinely for primary prevention. After an atherosclerotic event or stent, antiplatelet treatment is often important, but the choice depends on event type, bleeding risk, anticoagulants, and the treatment plan.

This advice reversed in the last decade. Three large trials showed that in healthy older adults, daily aspirin caused about as much serious bleeding as the heart trouble it prevented. For many people with established atherosclerotic disease, an appropriate antiplatelet regimen reduces recurrent events. Bleeding risk and anticoagulant use can change that plan. There is a middle group, such as people with a high calcium score, where it may still help. That is a decision to make with your cardiologist, not with a television commercial.

ILLUSTRATION. Picture a woman who runs regularly and develops unfamiliar jaw discomfort and breathlessness. She wonders whether fitness rules out a heart problem. It does not. Her clinician asks about the symptoms, her pregnancy history, and other risks rather than deciding that the explanation must be anxiety. A reassuring initial test can be useful without being the end of the investigation.

Clinical scenes in this edition are explicitly labeled illustrations. They describe imagined situations used to explain medical decisions, not documented patients, diagnoses, conversations, or treatment outcomes. They should not be read as evidence that a particular intervention works. Personal recollections are recollections, not medical records.

“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer

Evidence scope
ROBUST HUMAN TRIALS — Aspirin benefit and bleeding differ between primary and secondary prevention.Evidence grade (draft mapping)ARobust human trialsPart 3, Q34 · Part sources
All of Part 3

Related questions